Editas Medicine
EDIT
₹117.99
Share price
-1.44%
Change (1 day)
-82.06%
Change (1 year)
Editas Medicine (EDIT) - Cash on Hand
Cash on Hand as of December 2024 : ₹23.24 Billion
According to Editas Medicine
's latest financial reports the company has ₹23.24 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Editas Medicine - Cash on Hand chart (from 2014 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | ₹23.15 B | -13.92% |
| 2023-12-31 | ₹26.89 B | -5.58% |
| 2022-12-31 | ₹28.48 B | -23.43% |
| 2021-12-31 | ₹37.20 B | 26.51% |
| 2020-12-31 | ₹29.40 B | -9.79% |
| 2019-12-31 | ₹32.59 B | 26.36% |
| 2018-12-31 | ₹25.79 B | 22.76% |
| 2017-12-31 | ₹21.01 B | 66.88% |
| 2016-12-31 | ₹12.59 B | 32.35% |
| 2015-12-31 | ₹9.51 B | 1313.27% |
| 2014-12-31 | ₹0.67 B | 441.64% |
| 2013-12-31 | ₹0.12 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | ₹82.66 B | 255.62% | Jersey |
 | ₹79.50 B | 242.01% | 🇺🇸 USA |
 | ₹99.98 M | -99.57% | 🇺🇸 USA |
 | ₹10.80 B | -53.54% | 🇬🇧 UK |